Search

Search Constraints

You searched for: Author/Creator Stein, Harald

Search Results

11. PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial. Issue 6 (June 2021)

12. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Issue 10114 (23rd December 2017)

13. Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis – a consensus‐based study. Issue 6 (20th November 2015)

14. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group. Issue 4 (April 2017)

15. Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German Hodgkin Study Group. Issue 1 (December 2017)

17. The impact of SOCS1 mutations in diffuse large B‐cell lymphoma. (12th August 2019)

18. The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer. Issue 6 (8th June 2007)

19. The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma. Issue 11 (21st August 2019)

20. TP53 mutation and survival in aggressive B cell lymphoma. Issue 7 (26th June 2017)